|
gptkbp:instance_of
|
gptkb:Planned_Parenthood
|
|
gptkbp:approves
|
gptkb:2001
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Nuva_Ring
|
|
gptkbp:clinical_trial
|
conducted for safety
conducted for efficacy
|
|
gptkbp:contraindication
|
certain cancers
history of blood clots
smoking over age 35
|
|
gptkbp:demographics
|
women of reproductive age
|
|
gptkbp:drug_interactions
|
antibiotics
anticonvulsants
HIV medications
|
|
gptkbp:duration
|
one month
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Nuva Ring
|
|
gptkbp:ingredients
|
gptkb:ethinyl_estradiol
etonogestrel
|
|
gptkbp:insertion_frequency
|
once a month
|
|
gptkbp:is_effective_against
|
over 99% with perfect use
91% with typical use
|
|
gptkbp:manufacturer
|
gptkb:Merck_&_Co.
|
|
gptkbp:marketed_as
|
contraceptive ring
|
|
gptkbp:packaging
|
single-use ring
|
|
gptkbp:patient_education
|
informed about side effects
advised on missed doses
instructed on proper use
|
|
gptkbp:regulatory_compliance
|
prescription only
|
|
gptkbp:related_products
|
gptkb:patches
injection
IUD
|
|
gptkbp:release_region
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:removal_frequency
|
after three weeks
|
|
gptkbp:replaced_by
|
birth control pills
|
|
gptkbp:research_focus
|
user satisfaction
long-term effects
comparative effectiveness
|
|
gptkbp:return_to_fertility
|
immediate after removal
|
|
gptkbp:route_of_administration
|
vaginal
|
|
gptkbp:side_effect
|
gptkb:depression
heart attack
headache
nausea
stroke
hypertension
weight gain
breast tenderness
mood changes
thromboembolism
menstrual changes
gallbladder disease
vaginal discharge
vaginal irritation
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:type
|
gptkb:Planned_Parenthood
|
|
gptkbp:usage
|
prevent pregnancy
|
|
gptkbp:bfsParent
|
gptkb:Ortho_Tri-Cyclen
gptkb:Schering-Plough
|
|
gptkbp:bfsLayer
|
5
|